Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3093 |
|
Actual shortage: | 247 (8%) | |
Anticipated shortage: | 14 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2823 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-COLESEVELAM | 625MG | TABLET | Resolved | 2022-03-11 | 2022-04-01 | 156537 |
APO-COLESEVELAM | 625MG | TABLET | Resolved | 2022-11-04 | 2023-02-09 | 173826 |
APO-COLESEVELAM | 625MG | TABLET | Resolved | 2023-04-21 | 2023-07-27 | 190011 |
APO-COLESEVELAM | 625MG | TABLET | Resolved | 2023-11-17 | 2023-12-22 | 210674 |
APO-COLESEVELAM | 625MG | TABLET | Actual shortage | 2024-01-19 | 2024-05-10 | 216646 |
APO-RIVASTIGMINE | 6MG | CAPSULE | Resolved | 2017-07-26 | 2018-03-27 | 17322 |
APO-PACLITAXEL INJECTABLE | 6MG | SOLUTION | Actual shortage | 2017-08-14 | 2017-10-05 | 19133 |
APO-HYDROMORPHONE CR | 6MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-01-03 | 2020-04-04 | 71124 |
APO-RIVASTIGMINE | 6MG | CAPSULE | Resolved | 2019-07-03 | 2019-10-07 | 88360 |
APO-RIVASTIGMINE | 6MG | CAPSULE | Resolved | 2021-12-03 | 2021-12-13 | 150440 |
APO-MELOXICAM | 7.5MG | TABLET | Resolved | 2017-05-04 | 2017-10-05 | 8871 |
APO-OLANZAPINE | 7.5MG | TABLET | Resolved | 2017-05-10 | 2017-06-13 | 9933 |
APO-MELOXICAM | 7.5MG | TABLET | Resolved | 2017-05-16 | 2017-07-13 | 10424 |
APO-OLANZAPINE | 7.5MG | TABLET | Resolved | 2017-07-26 | 2017-10-05 | 17257 |
APO-ZOPICLONE | 7.5MG | TABLET | Resolved | 2017-08-16 | 2017-10-19 | 19558 |
APO-ZOPICLONE | 7.5MG | TABLET | Resolved | 2017-09-04 | 2017-10-18 | 20912 |
APO-OLANZAPINE | 7.5MG | TABLET | Resolved | 2017-11-09 | 2018-01-10 | 28689 |
APO-MELOXICAM | 7.5MG | TABLET | Resolved | 2018-08-27 | 2019-05-21 | 59302 |
APO-ZOPICLONE | 7.5MG | TABLET | Resolved | 2018-08-27 | 2018-10-05 | 59308 |
APO-OLANZAPINE | 7.5MG | TABLET | Resolved | 2019-02-13 | 2019-03-30 | 75623 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71032 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71035 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71038 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71051 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71057 | ||
ACID CONTROL | Discontinued | 2019-01-04 | 2019-01-04 | 71198 | ||
APO-RIZATRIPTAN RPD | Discontinued | 2019-01-04 | 2019-04-04 | 71334 | ||
APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78141 | ||
APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78144 | ||
APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83971 | ||
APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83976 | ||
APO-AMOXI CLAV 250MG/62.5MG PER 5ML | Discontinued | 2019-05-13 | 2019-05-13 | 83981 | ||
APO-AMOXI CLAV | Discontinued | 2019-05-17 | 2019-05-18 | 84392 | ||
APO-CEFPROZIL | Discontinued | 2019-05-17 | 2019-05-18 | 84396 | ||
APO-CEFPROZIL | Discontinued | 2019-06-12 | 2019-06-12 | 86542 | ||
APO-CIPROFLOX | Discontinued | 2019-06-12 | 2019-06-12 | 86547 | ||
APO-EXEMESTANE | Discontinued | 2019-06-12 | 2019-06-12 | 86552 | ||
APO-GEMFIBROZIL CAP 300MG USP | Discontinued | 2019-06-12 | 2019-06-12 | 86557 |